Helius Medical Technologies, Inc. (OTCMKTS:HSDT) Director Dane Andreeff bought 167,000 shares of the company’s stock in a transaction on Monday, November 13th. The shares were bought at an average price of $2.58 per share, for a total transaction of $430,860.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of Helius Medical Technologies, Inc. (OTCMKTS HSDT) opened at $2.21 on Thursday. Helius Medical Technologies, Inc. has a 12-month low of $1.29 and a 12-month high of $4.14.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Markets Daily and is owned by of Markets Daily. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2017/11/16/insider-buying-helius-medical-technologies-inc-hsdt-director-buys-430860-00-in-stock.html.
About Helius Medical Technologies
Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.
Receive News & Ratings for Helius Medical Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.